Alithea Genomics logo — Large scale RNA sequencing. Made easy.

Alithea Genomics

Large scale RNA sequencing. Made easy.

Founded 2020 Switzerland Lausanne, Switzerland 28 employees Seed Total: $5.50M Biopharma, Biotechnology

General Information

Company Name Alithea Genomics
Founded Year 2020
Location Switzerland Lausanne, Switzerland
Employees 28
Industries Biopharma, Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Alithea Genomics. To contact Alithea Genomics, visit alitheagenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alithea Genomics compare?

A PDF of Alithea Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alithea Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alithea Genomics

Alithea Genomics is a Switzerland-based startup focusing on biopharma and biotechnology industries, founded in 2020. The company's slogan "Large scale RNA sequencing. Made easy." reflects its core business of providing high throughput RNA sequencing in a user-friendly manner. With its recent Fr.2.80M Seed Round investment on 14 March 2024, Alithea Genomics secured backing from prominent investors including TechU Ventures and Novalis Biotech. This investment is a testament to the potential seen in the company's approach to simplifying a complex process, and it positions Alithea Genomics as a promising player in the genomics space.

Business keywords: RNA sequencing, high throughput sequencing, bioengineering, molecular biology, genomics, lab operations

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Fr.2.80M 2
TechU Ventures, Novalis Biotech
14 Mar 2024
Debt Financing Fr.500.00K 1
Foundation for Technological Innovation (FIT)
21 Mar 2023
Grant €1.00M 1
Eurostars
19 Jan 2023
Seed Round Fr.1.00M 1
Novalis Biotech
24 May 2022
Debt Financing Fr.100.00K 1
Foundation for Technological Innovation (FIT)
11 Mar 2021
Grant Fr.100.00K 1
Foundation for Technological Innovation (FIT)
09 Jun 2020

Alithea Genomics Alternatives & Competitors

View All Alternatives
Alithea Genomics vs

Our goal is to enable the analysis of anything, by anyone, anywhere.

Post-IPO Equity
1341 employees
Biopharma, Biotechnology
Alithea Genomics vs

Genetic medicines for genetic diseases

103 employees
Biopharma, Biotechnology
Alithea Genomics vs
Ailurus Bio
Ailurus Bio United Kingdom

Programming biology to automate and accelerate science.

17 employees
Biopharma, Biotechnology

FAQ About Alithea Genomics

Large scale RNA sequencing. Made easy.
Alithea Genomics was founded in 2020.
Alithea Genomics is headquartered in Lausanne, Switzerland.
Alithea Genomics operates in Biopharma and Biotechnology. Its work centres on RNA sequencing, high throughput sequencing, bioengineering and molecular biology.
Alithea Genomics has approximately 28 employees.
Alithea Genomics has completed 6 funding rounds, raising a total of $5.50M. The latest funding stage is Seed.
Top alternatives and competitors to Alithea Genomics include Oxford Nanopore Technologies, Arbor Biotechnologies, Ailurus Bio, PhiTech, CAMP4 Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alithea Genomics and Oxford Nanopore Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alithea Genomics, https://bouncewatch.com/company/alithea-genomics, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes